Skip to content

Clinical trials

Lymphoma, B-Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Japan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20091
20101
20131
20141
20162
20171
20181
20194
20203
20215
20223
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting11
Recruiting7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.6
AstraZeneca4
Novartis Pharmaceuticals4
Celgene2
Eisai Co., Ltd.2
Pfizer2
Acerta Pharma BV1
Bayer1
BeOne Medicines1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell32
Lymphoma, Non-Hodgkin20
Lymphoma, Large B-Cell, Diffuse12
Lymphoma, Follicular11
Lymphoma8
Lymphoma, Mantle-Cell8
Leukemia, Lymphocytic, Chronic, B-Cell7
Recurrence7
Hematologic Diseases5
Lymphoma, B-Cell, Marginal Zone5

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.